These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 186538)
1. Trypsin-induced increase in intracellular cyclic AMP of lymphocytes. Shneyour A; Patt Y; Trainin N J Immunol; 1976 Dec; 117(6):2143-9. PubMed ID: 186538 [TBL] [Abstract][Full Text] [Related]
2. Elevation of intracellular cAMP in human T lymphocytes by an anti-CD44 mAb. Rothman BL; Kennure N; Kelley KA; Katz M; Aune TM J Immunol; 1993 Dec; 151(11):6036-42. PubMed ID: 7504012 [TBL] [Abstract][Full Text] [Related]
3. Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levels. Ishihara K; Ono S; Takahama Y; Hirayama F; Hirano H; Itoh K; Dobashi K; Murakami S; Katoh Y; Yamaguchi M Immunology; 1989 Oct; 68(2):154-62. PubMed ID: 2553585 [TBL] [Abstract][Full Text] [Related]
4. Hydrocortisone and human lymphocytes: increases in cyclic adenosine 3':5'-monophosphate and potentiation of adenylate cyclase-activating agents. Marone G; Lichtenstein LM; Plaut M J Pharmacol Exp Ther; 1980 Nov; 215(2):469-78. PubMed ID: 6255128 [TBL] [Abstract][Full Text] [Related]
5. The role of cyclic AMP in modulating cytotoxic T lymphocytes. II. Sequential changes during culture in responsiveness of cytotoxic lymphocytes to cyclic AMP-active agents. Plaut M; Marone G; Gillespie E J Immunol; 1983 Dec; 131(6):2945-52. PubMed ID: 6315818 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression. Chouaib S; Welte K; Mertelsmann R; Dupont B J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362 [TBL] [Abstract][Full Text] [Related]
7. Stimulation by alcohols of cyclic AMP metabolism in human leukocytes. Possible role of cyclic AMP in the anti-inflammatory effects of ethanol. Atkinson JP; Sullivan TJ; Kelly JP; Parker CW J Clin Invest; 1977 Aug; 60(2):284-94. PubMed ID: 194924 [TBL] [Abstract][Full Text] [Related]
8. Cellular action of vasopressin in medullary tubules of mice with hereditary nephrogenic diabetes insipidus. Jackson BA; Edwards RM; Valtin H; Dousa TP J Clin Invest; 1980 Jul; 66(1):110-22. PubMed ID: 6249843 [TBL] [Abstract][Full Text] [Related]
9. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Marcoz P; Prigent AF; Lagarde M; Nemoz G Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905 [TBL] [Abstract][Full Text] [Related]
10. Protease potentiation of thymocyte blastogenesis. Ulrich F Immunology; 1979 Dec; 38(4):705-15. PubMed ID: 316417 [TBL] [Abstract][Full Text] [Related]
11. Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways. Butler JJ; Mader JS; Watson CL; Zhang H; Blay J; Hoskin DW J Cell Biochem; 2003 Aug; 89(5):975-91. PubMed ID: 12874832 [TBL] [Abstract][Full Text] [Related]
12. The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy. Cheng JB; Watson JW; Pazoles CJ; Eskra JD; Griffiths RJ; Cohan VL; Turner CR; Showell HJ; Pettipher ER J Pharmacol Exp Ther; 1997 Feb; 280(2):621-6. PubMed ID: 9023272 [TBL] [Abstract][Full Text] [Related]
13. Augmentation of postconfluence growth arrest of 10T1/2 fibroblasts by endogenous cyclic adenosine 3':5'-monophosphate. Matsukawa T; Bertram JS Cancer Res; 1988 Apr; 48(7):1874-81. PubMed ID: 2832054 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E modulation of the mitogenic response of human T cells. Differential response of T-cell subpopulations. Stobo JD; Kennedy MS; Goldyne ME J Clin Invest; 1979 Nov; 64(5):1188-203. PubMed ID: 227926 [TBL] [Abstract][Full Text] [Related]
15. The regulation of the immune response to polyvinylpyrollidone: antigen induced changes in prostaglandin and cyclic nucleotide levels. Zimecki M; Webb DR; Rogers TJ Arch Immunol Ther Exp (Warsz); 1980; 28(2):179-97. PubMed ID: 6255889 [TBL] [Abstract][Full Text] [Related]
16. Changes in cyclic adenosine 3':5'-monophosphate-dependent protein kinases during the progression of urethan-induced mouse lung tumors. Butley MS; Stoner GD; Beer DG; Beer DS; Mason RJ; Malkinson AM Cancer Res; 1985 Aug; 45(8):3677-85. PubMed ID: 2990675 [TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP concentrations modulate both calcium flux and hydrolysis of phosphatidylinositol phosphates in mouse T lymphocytes. Lerner A; Jacobson B; Miller RA J Immunol; 1988 Feb; 140(3):936-40. PubMed ID: 2828473 [TBL] [Abstract][Full Text] [Related]
18. Regulation of cAMP-responsive enhancer binding proteins during cell cycle progression in T lymphocytes stimulated by IL-2. Feuerstein N; Huang D; Hinrichs SH; Orten DJ; Aiyar N; Prystowsky MB J Immunol; 1995 Jan; 154(1):68-79. PubMed ID: 7995960 [TBL] [Abstract][Full Text] [Related]
19. Cyclic AMP is an essential factor in immune responses. Koh WS; Yang KH; Kaminski NE Biochem Biophys Res Commun; 1995 Jan; 206(2):703-9. PubMed ID: 7826390 [TBL] [Abstract][Full Text] [Related]
20. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3',5'-cyclic monophosphate production in T lymphocytes. Hahn WC; Rosenstein Y; Burakoff SJ; Bierer BE J Immunol; 1991 Jul; 147(1):14-21. PubMed ID: 1711070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]